Search research articles
Contact Us
Filters
Showing results (81-90 of 95) with videos related to
Page
of 10
Sort By:
Transplantation and Cellular Therapy
|
August 8, 2022
Deepening Responses after Upfront Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma in the Era of Novel Agent Induction Therapy
Mohammad Ebraheem, Shaji K Kumar, Angela Dispenzieri, et al.
Blood Advances
|
May 23, 2020
Metaphase cytogenetics and plasma cell proliferation index for risk stratification in newly diagnosed multiple myeloma
Patrick W Mellors, Moritz Binder, Rhett P Ketterling, et al.
Blood Cancer Journal
|
September 29, 2025
Impact of residual clonal plasma cells in S-phase at the time of autologous stem cell transplantation on clinical outcomes
Tamer Hellou, Daniel G Packard, Suheil Albert Atallah-Yunes, et al.
Blood Advances
|
December 4, 2024
Single-cell multiomics reveal divergent effects of DNMT3A- and TET2-mutant clonal hematopoiesis in inflammatory response
Wazim Mohammed Ismail, Jenna A Fernandez, Moritz Binder, et al.
American Journal of Hematology
|
October 13, 2022
Risk factors for severe infection and mortality In patients with COVID-19 in patients with multiple myeloma and AL amyloidosis
Matthew Ho, Saurabh Zanwar, Francis K Buadi, et al.
American Journal of Hematology
|
June 4, 2026
Patterns of Progression and Clinical Outcomes After First Progression in Patients With Primary Plasma Cell Leukemia
Daniel G Packard, Shaji K Kumar, Angela Dispenzieri, et al.
Blood Cancer Journal
|
February 1, 2022
A simple additive staging system for newly diagnosed multiple myeloma
Nadine H Abdallah, Moritz Binder, S Vincent Rajkumar, et al.
Blood Advances
|
April 9, 2026
Determinants of Gastrointestinal Disease Burden and Survival in Systemic AL Amyloidosis
Maximilian Johannes Steinhardt, Eli Muchtar, Taxiarchis V Kourelis, et al.
Blood Cancer Journal
|
June 23, 2026
Characteristics and outcomes of secondary hematological malignancies following autologous stem cell transplantation for multiple myeloma
Binoy Yohannan, Benjamin W Langworthy, Lindsey E Turner, et al.
Haematologica
|
March 5, 2026
Real-world outcomes of newly diagnosed multiple myeloma patients treated with front-line daratumumab bortezomib lenalidomide and dexamethasone
Ricardo D Parrondo, Ricardo De Menezes, Hanna Sledge, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 95) with videos related to
Sort By:
Page
of 10
Transplantation and Cellular Therapy
|
August 8, 2022
Deepening Responses after Upfront Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma in the Era of Novel Agent Induction Therapy
Mohammad Ebraheem, Shaji K Kumar, Angela Dispenzieri, et al.
Blood Advances
|
May 23, 2020
Metaphase cytogenetics and plasma cell proliferation index for risk stratification in newly diagnosed multiple myeloma
Patrick W Mellors, Moritz Binder, Rhett P Ketterling, et al.
Blood Cancer Journal
|
September 29, 2025
Impact of residual clonal plasma cells in S-phase at the time of autologous stem cell transplantation on clinical outcomes
Tamer Hellou, Daniel G Packard, Suheil Albert Atallah-Yunes, et al.
Blood Advances
|
December 4, 2024
Single-cell multiomics reveal divergent effects of DNMT3A- and TET2-mutant clonal hematopoiesis in inflammatory response
Wazim Mohammed Ismail, Jenna A Fernandez, Moritz Binder, et al.
American Journal of Hematology
|
October 13, 2022
Risk factors for severe infection and mortality In patients with COVID-19 in patients with multiple myeloma and AL amyloidosis
Matthew Ho, Saurabh Zanwar, Francis K Buadi, et al.
American Journal of Hematology
|
June 4, 2026
Patterns of Progression and Clinical Outcomes After First Progression in Patients With Primary Plasma Cell Leukemia
Daniel G Packard, Shaji K Kumar, Angela Dispenzieri, et al.
Blood Cancer Journal
|
February 1, 2022
A simple additive staging system for newly diagnosed multiple myeloma
Nadine H Abdallah, Moritz Binder, S Vincent Rajkumar, et al.
Blood Advances
|
April 9, 2026
Determinants of Gastrointestinal Disease Burden and Survival in Systemic AL Amyloidosis
Maximilian Johannes Steinhardt, Eli Muchtar, Taxiarchis V Kourelis, et al.
Blood Cancer Journal
|
June 23, 2026
Characteristics and outcomes of secondary hematological malignancies following autologous stem cell transplantation for multiple myeloma
Binoy Yohannan, Benjamin W Langworthy, Lindsey E Turner, et al.
Haematologica
|
March 5, 2026
Real-world outcomes of newly diagnosed multiple myeloma patients treated with front-line daratumumab bortezomib lenalidomide and dexamethasone
Ricardo D Parrondo, Ricardo De Menezes, Hanna Sledge, et al.
Page
of 10